EconPapers    
Economics at your fingertips  
 

Stability of Virus Infection Models with Antibodies and Chronically Infected Cells

Mustafa A. Obaid and A. M. Elaiw

Abstract and Applied Analysis, 2014, vol. 2014, 1-12

Abstract:

Two virus infection models with antibody immune response and chronically infected cells are proposed and analyzed. Bilinear incidence rate is considered in the first model, while the incidence rate is given by a saturated functional response in the second one. One main feature of these models is that it includes both short-lived infected cells and chronically infected cells. The chronically infected cells produce much smaller amounts of virus than the short-lived infected cells and die at a much slower rate. Our mathematical analysis establishes that the global dynamics of the two models are determined by two threshold parameters and . By constructing Lyapunov functions and using LaSalle's invariance principle, we have established the global asymptotic stability of all steady states of the models. We have proven that, the uninfected steady state is globally asymptotically stable (GAS) if , the infected steady state without antibody immune response exists and it is GAS if , and the infected steady state with antibody immune response exists and it is GAS if . We check our theorems with numerical simulation in the end.

Date: 2014
References: Add references at CitEc
Citations:

Downloads: (external link)
http://downloads.hindawi.com/journals/AAA/2014/650371.pdf (application/pdf)
http://downloads.hindawi.com/journals/AAA/2014/650371.xml (text/xml)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hin:jnlaaa:650371

DOI: 10.1155/2014/650371

Access Statistics for this article

More articles in Abstract and Applied Analysis from Hindawi
Bibliographic data for series maintained by Mohamed Abdelhakeem ().

 
Page updated 2025-03-19
Handle: RePEc:hin:jnlaaa:650371